Update in pulmonary carcinoid tumors: a review article

…, CA Seldenrijk, JMM Van den Bosch - Annals of Surgical …, 2003 - Springer
Pulmonary carcinoid tumors are neuroendocrine malignant tumors that make up 1% to 2% of
all lung tumors. According to histopathologic criteria, carcinoids can be divided into typical (…

Corticosteroid treatment in sarcoidosis

JC Grutters, JMM Van den Bosch - European Respiratory …, 2006 - Eur Respiratory Soc
At present there is no curative treatment for sarcoidosis. Immunosuppressive and/or
immunomodulatory drugs can, however, be used for controlling the disease. Corticosteroids remain …

[HTML][HTML] High-dose acetylcysteine in idiopathic pulmonary fibrosis

…, P De Vuyst, JMM Van Den Bosch… - … England Journal of …, 2005 - Mass Medical Soc
Background Idiopathic pulmonary fibrosis is a chronic progressive disorder with a poor
prognosis. Methods We conducted a double-blind, randomized, placebo-controlled multicenter …

Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA

MTM van Rens, JMM van den Bosch, AB de la Rivière… - Chest, 2000 - Elsevier
Study objectives Staging and classification in lung cancer are important for both patient
management and clinical research. Results of survival after resection in patients with primary non…

Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort

…, HW van Es, JMM van den Bosch… - American journal of …, 2010 - atsjournals.org
van Moorsel C, van Oosterhout MFM, Ruven HJT, van den Bosch JMM, Grutters JC. The
occurrence and clinical characteristics of SFTPC mutations in familial idiopathic pulmonary …

Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation

…, R Janssen, JMM van den Bosch, H van Velzen-Blad - Chest, 2003 - Elsevier
Objectives To date, insufficient evidence is available to recommend serum soluble
interleukin-2 receptor (sIL-2R) measurement as a routine test in the assessment of sarcoidosis. …

Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease

…, L Koenderman, JMM Van den Bosch - Clinical & …, 2009 - academic.oup.com
Systemic inflammation can be investigated by changes in expression profiles of neutrophil
receptors. Application of this technology for analysis of neutrophil phenotypes in diseased …

HLA-DQB1* 0201: a marker for good prognosis in British and Dutch patients with sarcoidosis

…, JWJ Lammers, JMM Van Den Bosch… - American journal of …, 2002 - atsjournals.org
Human leukocyte antigen (HLA)-DQB1 is one of the intriguing candidate genes in sarcoidosis.
We performed high resolution molecular HLA-DQB1 typing on two groups of white …

[HTML][HTML] Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis

…, HJT Ruven, A Kruit, M Heron, JMM van den Bosch… - Respiratory …, 2011 - Elsevier
BACKGROUND: The chitinase-like protein YKL-40 is a serum biomarker in diseases with
fibrosis, inflammation and tissue remodelling. Idiopathic pulmonary fibrosis (IPF) is a …

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups

…, P Spagnolo, JMM van den Bosch… - Human molecular …, 2010 - academic.oup.com
The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several
groups but often without consistent results. In this paper, we consider the hypothesis that …